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Improved Sample Capsule for Determination of

Oxygen in Hemolyzed Blood 
Measurements of oxygen saturation in hemolyzed 
bloo, based upon the spectrophotometric method 
described in Tech Brief B67-10252, have inherent 
limitations in attainable accuracy, particularly at low 
levels of oxygen saturation, which arise as a con-
sequence of the operations involved in sample prepa-
ration. A sample capsule was designed to eliminate 
errors arising from air entrainment which may occur 
with standard glass syringes, both during sample 
withdrawal and during the introduction of a hemolyz-
ing agent. The new sample capsule obviates the need 
for the addition of mercury for mixing and the need 
for syringe lubricant, both of which are potential 
sources of sample contamination. 
The sample capsule consists of a measured section 
of pzilytetrafluoroethylene tubing equipped at each 
end with a connector and a stopcock valve. Hemolysis 
is accomplished by injection into the capsule of a buf-
fered hemolyzing agent with a 5-inch No. 20 needle 
through a capsule end valve shielded with a 1-inch 
No. 15 needle. Mixing is accomplished by means of a 
0.125-inch brass cube housed in the capsule. Delivery 
of hemolyzed blood into 0.1-mm spectrophotometric
cuvette cells is accomplished through a No. 20 needle-
equipped end valve by a screw-driven pressure plate. 
Notes: 
1. The capsule is designed for use in closed circulating 
systems and is unsuitable for general purpose blood 
sampling from individual subjects. 
2. Inquiries concerning the design and use of the 
sample capsule may be directed to: 
Technology Utilization Officer 
Manned Spacecraft Center 
Houston, Texas 77058 
Reference: B67-10408 
Patent status: 
Inquiries about obtaining rights for the commercial 
use of this invention may be made to NASA, Code 
GP, Washington, D.C. 20546.
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